Vasodilator action of guinea pig vasoactive intestinal polypeptide (VIP): comparison with common mammalian VIP.
The vascular activity of guinea pig (gp) and common mammalian (p) VIP were compared in anesthetized guinea pigs and dogs. In the guinea pig, intravenous injections of gpVIP and pVIP increased pancreatic blood flow and reduced the systemic arterial pressure and pancreatic vascular resistance in a dose-related manner. There were no significant differences in the vasodilator actions of these two VIPs, indicating that the overall cardiovascular actions of gpVIP and pVIP are similar in guinea pigs. In the dog, gpVIP, when given intra-arterially, was less potent (about 1/4) than pVIP in its action on femoral blood flow, suggesting that the blood vessels of the dog hind leg are more sensitive to its own VIP than to gpVIP. Oxidation of pVIP and gpVIP with H2O2 greatly reduced their vasodilator effects on the femoral arterial blood flow. The vascular effects were restored to control levels by reduction of the oxidized peptides with mercaptoethanol, which suggests that methionine residues of gpVIP and pVIP are important in the vasodilator effect on the femoral arterial bed in dogs.
Naruse
S
S
National Institute for Physiological Sciences, Okazaki, Japan.
Inoue
T
T
Mochizuki
T
T
Yanaihara
N
N
D000818:Animals; D001783:Blood Flow Velocity / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D005263:Femoral Artery / Q000187:drug effects; D006168:Guinea Pigs; D007275:Injections, Intravenous; D008297:Male; D010084:Oxidation-Reduction / Q000187:drug effects; D010179:Pancreas / Q000098:blood supply / Q000187:drug effects; D013045:Species Specificity; D013329:Structure-Activity Relationship; D014660:Vasoactive Intestinal Peptide / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D014664:Vasodilation / Q000187:drug effects*
D014660:Vasoactive Intestinal Peptide